Tonix Pharmaceuticals Holding Corp. Logo

Tonix Pharmaceuticals Holding Corp.

Develops therapies and vaccines for complex conditions and public health challenges.

TNXP | US

Overview

Corporate Details

ISIN(s):
US8902608392
LEI:
Country:
United States of America
Address:
26 MAIN STREET, SUITE 101, 7928 CHATHAM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that develops therapies and vaccines for complex, chronic conditions and public health challenges. The company's pipeline is focused on four main therapeutic areas: Central Nervous System (CNS) disorders, immunology, infectious diseases, and rare diseases. Key development programs include treatments for acute stress disorder, organ transplant rejection, Prader-Willi syndrome, and various cancers. Tonix also utilizes an in-house live virus vaccine platform to develop biodefense countermeasures against pathogens such as mpox and smallpox. The company's approach is centered on addressing unmet medical needs through scientific development of its portfolio of investigational product candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Tonix Pharmaceuticals Holding Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Tonix Pharmaceuticals Holding Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Tonix Pharmaceuticals Holding Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

YD Bio Ltd Logo
Developing blood-based cancer detection and regenerative therapies for biopharma partners.
United States of America
YDES
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea
000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan
4531
Zai Lab Ltd Logo
Global biopharma firm developing therapies for oncology, immunology, neuroscience & infectious diseases.
United States of America
ZLAB
Zealand Pharma Logo
Developing innovative peptide medicines for metabolic and inflammatory diseases.
Denmark
ZEAL
Zelluna ASA Logo
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
Norway
ULTI
Zenas BioPharma, Inc. Logo
Clinical-stage biopharma developing immunology-based therapies for autoimmune diseases.
United States of America
ZBIO
Zentalis Pharmaceuticals, Inc. Logo
Develops small molecule cancer drugs, led by a first-in-class oral WEE1 inhibitor for tumors.
United States of America
ZNTL
Zentiva 2 Logo
European provider of high-quality, affordable generic and over-the-counter medicines.
Slovakia
SKF

Talk to a Data Expert

Have a question? We'll get back to you promptly.